CXR Biosciences

About:

CXR Biosciences offers preclinical services in investigative toxicology, metabolism, pharmacokinetics, and exploratory/discovery toxicology.

Website: http://www.cxrbiosciences.com

Twitter/X: cxr_biosciences

Top Investors: Archangels, Scottish Investment Bank

Description:

CXR Biosciences is advancing and commercializing innovative approaches to transform the drug development and chemical safety assessment process. As well as introducing new technology platforms to the marketplace, CXR also helps customers to take their candidate compounds through development efficiently, or to resolve problems that have been encountered, through the provision of customized solutions. The company has business relationships with over sixty customers and collaborators, including pharmaceutical companies, chemical companies, biotechnology companies, leading universities and research institutions.

Total Funding Amount:

1.3M GBP

Headquarters Location:

Snodland, Kent, United Kingdom

Founded Date:

2001-12-01

Contact Email:

info(AT)cxrbiosciences.com

Founders:

Cliff Elcombe

Number of Employees:

11-50

Last Funding Date:

2008-02-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai